Partial Response to Lorlatinib in Thoracic Inflammatory Myofibroblastic Tumor Harboring Complex and Rare ALK Fusions: a Case Report.
Translational lung cancer research(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined